Additional products are available to SENSIGHT subscribers, for specific research projects. Fees are costed on a project-specific basis.
Sensyne’s Biomarker Search service will, where possible, link genomic or panomic data to real world Electronic Patient Record (EPR) data to allow the association between SNPs, protein and disease expression to further increase confidence in target selection and facilitate the development of personalised medicines.
Sensyne Health can act as a trusted intermediary in the provision of data between supplier and payer using real world data obtained from the SENSIGHT platform.
Leveraging large anonymised patient data sets and clinical expertise within the SENSIGHT platform, along with Sensyne’s imaging expertise, enables the rapid development of prototype AI applications to address research problems.